Company intelligence / Profile preview

Biomoda

Albuquerque, New Mexico, United Statesbrandbucket.com ↗

Ownership: Private
Development stage: Other

Overview

Biomoda developed an in vitro diagnostic platform based on a patented fluorescent assay that identifies cancerous or aberrant cells from lung sputum samples. The technology was selected for clinical studies focused on early detection of lung cancer. There are no published results indicating commercial launch or regulatory approval.

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic assayIn vitro diagnostic test
Industry: Pathology

Beyond the preview

Go deeper on Biomoda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomoda.

Explore the full profile